Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L W Ellisen

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Oncogene|March 6, 2007
p63 and p73 in human cancer: defining the networkM P Deyoung, L W Ellisen
Annual Review of Medicine|March 24, 1998
Hereditary breast cancerL W Ellisen, D A Haber
British Journal of Cancer|September 24, 2009
Mutant p53 mediates survival of breast cancer cellsL Y Lim, N Vidnovic, L W Ellisen, et al.
The EMBO Journal|April 11, 2001
The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cellsL W Ellisen, N Carlesso, T Cheng, et al.
The Journal of Biological Chemistry|March 30, 2001
A functional interaction with CBP contributes to transcriptional activation by the Wilms tumor suppressor WT1W Wang, S B Lee, R Palmer, et al.
The American Journal of Pathology|March 1, 1987
Clonal T-cell populations in pityriasis lichenoides et varioliformis acuta (Mucha-Habermann disease)L M Weiss, G S Wood, L W Ellisen, et al.
Cell|August 23, 1991
TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasmsL W Ellisen, J Bird, D C West, et al.
European Journal of Cell Biology|July 4, 2001
Cascades of transcriptional induction during human lymphocyte activationL W Ellisen, R E Palmer, R G Maki, et al.
Oncogene|April 7, 1998
Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomeraseC M Counter, M Meyerson, E N Eaton, et al.
Nature Genetics|June 10, 1998
Expression of TERT in early premalignant lesions and a subset of cells in normal tissuesK A Kolquist, L W Ellisen, C M Counter, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Oncogene|March 6, 2007
p63 and p73 in human cancer: defining the networkM P Deyoung, L W Ellisen
Annual Review of Medicine|March 24, 1998
Hereditary breast cancerL W Ellisen, D A Haber
British Journal of Cancer|September 24, 2009
Mutant p53 mediates survival of breast cancer cellsL Y Lim, N Vidnovic, L W Ellisen, et al.
The EMBO Journal|April 11, 2001
The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cellsL W Ellisen, N Carlesso, T Cheng, et al.
The Journal of Biological Chemistry|March 30, 2001
A functional interaction with CBP contributes to transcriptional activation by the Wilms tumor suppressor WT1W Wang, S B Lee, R Palmer, et al.
The American Journal of Pathology|March 1, 1987
Clonal T-cell populations in pityriasis lichenoides et varioliformis acuta (Mucha-Habermann disease)L M Weiss, G S Wood, L W Ellisen, et al.
Cell|August 23, 1991
TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasmsL W Ellisen, J Bird, D C West, et al.
European Journal of Cell Biology|July 4, 2001
Cascades of transcriptional induction during human lymphocyte activationL W Ellisen, R E Palmer, R G Maki, et al.
Oncogene|April 7, 1998
Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomeraseC M Counter, M Meyerson, E N Eaton, et al.
Nature Genetics|June 10, 1998
Expression of TERT in early premalignant lesions and a subset of cells in normal tissuesK A Kolquist, L W Ellisen, C M Counter, et al.
Pageof 2